Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC - Quiz - MDSpire

Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC

  • By

  • Lorenzo De Sanctis

  • Riccardo Ray Colciago

  • Giulia Rossano

  • Matteo Ferrari

  • Matteo Mombelli

  • Ilenia Manno

  • Federica Ferrario

  • Sara Saufi

  • Valeria Faccenda

  • Denis Panizza

  • Gaia Passarella

  • Stefania Canova

  • Diego Luigi Cortinovis

  • Stefano Arcangeli

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC

  • by Lorenzo De Sanctis, Riccardo Ray Colciago, Giulia Rossano, Matteo Ferrari, Matteo Mombelli, Ilenia Manno, Federica Ferrario, Sara Saufi, Valeria Faccenda, Denis Panizza, Gaia Passarella, Stefania Canova, Diego Luigi Cortinovis, Stefano Arcangeli

  • May 25, 2026

Related Content

FOXA2 in cancer: from fundamental biology to clinical translation

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant